OCT4

OCT4 Protein

Score: 0.455 Price: $0.48 Low Druggability Status: active
HYPOTHESES
1
PAPERS
23
KG EDGES
0
DEBATES
0

3D Protein Structure

🧬 OCT4 — PDB 3L1P Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

Druggability & Clinical Context

Druggability
Low
Score: 0.50
Clinical Stage
Phase II
Target Class
Protein
Safety
0.50
Druggability Analysis
Drug Development0.00
Structural Tractability0.30
Target Class0.50
Safety Profile0.50
Key Metrics
PDB Structures:
0
Known Drugs:
0
Approved:
0
In Clinical Trials:
0
Therapeutic Areas:
neurodegeneration
Mechanism: Prioritized from 1 SciDEX hypotheses, including: Partial Neuronal Reprogramming via Modified Yamanaka Cocktail
Known Drugs:
No known drugs targeting this protein
Structural Data:

🧬 3D Protein Structure

🧬 OCT4 — PDB 3L1P Click to expand interactive 3D viewer

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll

Linked Hypotheses (1)

Partial Neuronal Reprogramming via Modified Yamanaka Cocktail0.399

Linked Experiments (0)

No linked experiments

Scoring Dimensions

Portfolio 0.00 (25%) Druggability 0.50 (20%) Evidence 1.00 (20%) Safety 0.50 (15%) Competitive 0.40 (10%) Connectivity 0.00 (10%) 0.455 composite

Knowledge Graph (20)

activates (6)

OCT4 cellular_reprogramming
OCT4 POU5F1
OCT4 SOX2
OCT4 KLF4
OCT4 DNMT3A
...and 1 more

biomarker for (3)

OCT4 MYC
OCT4 SOX2
OCT4 KLF4

expressed in (2)

OCT4 SOX2
OCT4 MYC

implicated in (1)

OCT4 neurodegeneration

interacts with (1)

OCT4 SOX2

involved in (1)

OCT4 Self-Renewal

regulates (3)

OCT4 SOX2
OCT4 KLF4
OCT4 MYC

therapeutic target (3)

OCT4 neurodegeneration
OCT4 AKT
OCT4 MTOR

Debate History (0)

No debates yet